How much government spending will Trump cut before his term ends?
Assuming '250' means a $250 billion or greater reduction in annual federal outlays by the end of 2027, I assess ~22% probability that government spending will fall by that magnitude before 2028.
Analysis
**Assumptions and clarification (required)**: The question is ambiguous about units and timing. I assume it asks whether *annual federal government spending* (federal outlays) will be *reduced by at least $250 billion* relative to the baseline in force prior to the OBBBA, with that reduction occurring *before 2028* (i.e., by 12/31/2027 or in FY2027 outlays). All analysis below uses that interpretation.
Stage 1 — BLIND ANALYSIS (independent assessment, ignoring market prices)
Summary conclusion: given the OBBBA's text and CBO scoring (>$1 trillion in Medicaid reductions over ten years; ~$187 billion in SNAP cuts over ten years), the calendar/timing of implementation, historical experience with administrative rollouts, and the scale of federal outlays, a >=$250 billion *annual* reduction by the end of 2027 is possible but unlikely. My independent probability is 22%.
Reasoning and evidence (detailed):
- Scale and timing of OBBBA cuts: The law's headline numbers — >$1T Medicaid cuts and ~$187B SNAP reductions — are multi‑year totals spread over a decade. Even if they average ~ $100B/year for Medicaid and ~ $18B/year for SNAP, the bulk of the Medicaid reduction is phased in later (CBO and implementers have said the harshest provisions phase in around 2027–2028). That points to *smaller* annual reductions in 2025–2027 than the 10‑year average implies.
- Implementation schedule: Key elements (Medicaid work requirements) take effect beginning 12/31/2026 and are phased across states. Administrative rollout delays, state waiver approvals, operational churn, and elective legal challenges typically push large program impacts out by months/years. Realized federal savings in 2027 will therefore be a fraction of the 10‑year total.
- Magnitude versus federal outlays: Total federal outlays are large (~$6–7 trillion annually in recent years). A $250B reduction is a meaningful chunk (~3–4% of total outlays). Historically, rapid, across‑the‑board permanent reductions of this size in entitlement spending rarely manifest inside a ~12–18 month window, absent an economic crisis or outright statutory repeal of large programs.
- Offsetting dynamics: The same law that cuts spending also enacted sizable tax cuts that increase deficits, per CBO. Political pressure to offset visible harm (e.g., large Medicaid coverage losses) may cause states or Congress to protect certain populations or to pass mitigating measures, reducing net federal savings. States might backfill some cuts, blunting federal outlay declines. Additionally, other federal spending lines (discretionary appropriations, emergency response, defense, interest on debt) may rise or be reallocated, offsetting cuts in health and nutrition.
- Legal and political risk: Laws limiting benefits often face litigation and injunctions. Courts can pause implementation or force adjustments, which would truncate 2027 savings. Conversely, if the administration accelerates implementation and obtains rapid state waivers, realized savings could be frontloaded.
Numeric reasoning: A plausible central-case profile by end‑2027 is something like $70–160B/year in Medicaid+SNAP federal spending reductions actually realized (less than the 10‑year averages because of phasing). To reach ≥$250B/year by end‑2027 would require either (a) front‑loading of the OBBBA savings much faster than CBO baseline, (b) additional cuts/administrative rescissions in other large spending categories, or (c) favorable accounting choices (e.g., shifting program obligations out of the budget). Each is possible but not likely given historical precedent and the CBO timing.
Stage 2 — MARKET CALIBRATION (after seeing prices: Yes 0.15, No 0.85)
Market context: The market price implies a 15% probability for Yes, modestly below my independent 22% assessment. My read is that the market is applying additional discounting for (a) the ambiguity in the market question (no units/timing spelled out), (b) legal/judicial/administrative uncertainty, and (c) a conservative view that the 10‑year totals are poor predictors of near‑term annual drops.
Why the market may be cheaper than my independent view:
- Ambiguity discount: Traders often penalize ambiguous contracts heavily. If some participants interpreted '250' as $250m, $250b cumulative, or something else, they may be unwilling to bet on Yes aggressively.
- Risk aversion and liquidity: The event has substantial volume already; risk-averse professional traders may cap exposure to politically sensitive, legally uncertain outcomes, pushing the price lower.
- Conservative CBO reading: Many traders anchor to official CBO phasing estimates and therefore give low near‑term probability for realizing large annual cuts before 2028.
Why I think Yes is modestly underpriced (~22% vs. 15%):
- Tail risks and implementation speed: The administration could prioritize aggressive implementation, expedite waivers and regs, and pair administrative actions with budgetary maneuvers or rescissions that accelerate savings into 2027. That sequence is unlikely but not ruled out; it creates a measurable upside probability beyond what a purely CBO‑phased baseline captures.
- Measurement and accounting pathways: There are plausible accounting or definitional pathways (e.g., reclassifying spending, rescinding or not obligating funds) that can generate large nominal declines in federal outlays in a short window. Markets may underweight these nontraditional but feasible approaches.
Recommendation for traders: If you accept my interpretation of the question, buying Yes at 15% yields a positive expected edge against my 22% estimate, but position size should be small because of high uncertainty and ambiguity. If you are unsure of the units/definition, avoid the contract — ambiguity risk dominates.
Overall: I place 22% independent probability on a >=$250B annual federal spending reduction occurring before 2028. The market price (~15%) is slightly lower; I view that as a modest mispricing driven primarily by question ambiguity and risk aversion.
Arguments
For
- The OBBBA's statutory language and CBO scoring contain very large nominal cuts (>$1T Medicaid, ~$187B SNAP) that *could* be frontloaded into annual reductions if implementation is accelerated or accounting choices are used.
- Medicaid work requirements and eligibility changes begin around end‑2026; if states implement rapidly, 2027 federal outlays could decline materially relative to the prior baseline.
- Administrative levers (rescissions, non‑renewals, tightened guidance) can produce faster visible declines in outlays than slow statutory phase‑ins would suggest.
Against
- The CBO and public scoring spread the headline cuts over ten years; the likely realized reductions in 2027 are far smaller than the 10‑year totals imply, making a ≥$250B annual reduction by end‑2027 unlikely.
- Legal challenges, state waiver delay, and political pushback historically slow or blunt large entitlement changes, reducing near‑term realized savings.
- Other spending increases (interest on debt, emergency spending, or discretionary appropriations) and state backfilling will likely offset a large chunk of any direct Medicaid/SNAP federal reductions.
Key drivers
- OBBBA implementation schedule and the calendar phasing of Medicaid and SNAP changes
- CBO scoring and year‑by‑year estimates (how much of the 10‑year cuts show up in 2026–2027)
- Speed and scope of administrative actions (waivers, regs) and state waiver approvals
- Judicial challenges or injunctions that delay or block program changes
- Offsets from other spending changes (discretionary appropriations, emergency spending) and state backfilling
Risk factors
- Ambiguity in the contract's unit/timing definition leading to market confusion
- Slower-than-expected implementation and phased rollouts that defer savings into later years
- Legal rulings or injunctions halting key provisions (work requirements, eligibility changes)
- States choose to backfill lost federal support, reducing net federal outlays decline
- Countervailing increases in other federal spending lines or one-off emergency spending
Scenarios
Best case
Rapid, aggressive implementation: the administration accelerates waivers and regs, many large states adopt work requirements and eligibility changes quickly, courts do not block key provisions, and the administration pairs those actions with additional rescissions/administrative cuts. Together they produce a visible, nominal >=$250B decline in federal outlays by the end of 2027.
Most likely
Partial implementation leads to a meaningful but smaller drop in federal health and nutrition spending in 2027 (roughly $70–160B annual reduction). Offsetting factors (state backfill, other federal spending rises, delayed rollouts) keep the total short of the $250B threshold, so No prevails.
Worst case
Implementation stalls or is largely blocked: courts enjoin major provisions, states refuse to implement changes or backfill for affected populations, and other spending increases (or accounting conventions) offset any modest Medicaid/SNAP reductions. Net federal outlays do not decline and may rise — No outcome.
More from this day
- PoliticsKalshi2y
Which Supreme Court justices will resign during Trump's term?
AI8%MKT66%Edge-58HypedIndependent assessment: very unlikely that Justice Samuel Alito will resign during Trump's 2025–2029 term; I estimate an 8% chance he voluntarily resigns during that window.
- pop culturePolymarketEnded
What will Trump say during Press Conference in Turkey?
AI60%MKT3%Edge+57Hidden GemI assess a moderately high probability that Trump will say the words "Million," "Billion," or "Trillion" 20+ times during the Turkey press conference, mainly because of his documented habit of repeating numeric magnitudes and the likelihood he will pivot to domestic economic talking points during Q&A.
- FinancialsKalshi13y
Will OpenAI or Anthropic IPO first?
AI35%MKT82%Edge-47Hyped**Assumption:** 'Yes' = OpenAI will IPO before Anthropic. Independent assessment: I assign a 35% probability that OpenAI will IPO before Anthropic (i.e., Anthropic is more likely to be the first of the two to list).